VEEV — Veeva Systems Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Veeva Systems, fiscal year end - January 31st, USD millions except per share, conversion factor applied.

	2020 January 31st	2021 January 31st	2022 January 31st	2023 January 31st	2024 January 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,104	1,465	1,851	2,155	2,364
Cost of Revenue
Gross Profit	801	1,056	1,347	1,546	1,686
Selling / General / Administrative Expenses
Research And Development
Other Operating Expenses
Total Operating Expenses	818	1,087	1,345	1,696	1,934
Operating Profit	286	378	505	459	429
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	314	394	512	509	588
Provision for Income Taxes
Net Income After Taxes	301	380	427	488	526
Net Income Before Extraordinary Items
Net Income	301	380	427	488	526
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	354	401	490	553	569
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.9	3.19	3.02	3.41	4.38